Analysis of the prognostic role of plasmatic K-ras mutations in advanced non-small cell lung cancer (NSCLC) patients

被引：0
|
作者：
Sirera, R.
Camps, C.
Berrocal, A.
Munoz-Navarro, M.
Garcia-Gomez, R.
Vinolas, N.
Artal, A.
Guillot, M.
Taron, M.
Rosell, R.
机构：
[1] Hosp Gen Valencia, Valencia, Spain
[2] Hosp Gregorio Maranon, Madrid, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Miguel Servet, Zaragoza, Spain
[5] Hosp Son Dureta, Palma De Mallorca, Spain
[6] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18009
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC)
    Voutsina, A.
    Kalikaki, A.
    Ampatziadis-Michailidis, Y.
    Souglakos, J.
    Koytsopoylos, A.
    Trypaki, M.
    Pallis, A.
    Stathopoylos, S.
    Mavroudis, D.
    Georgoulias, V.
    EJC SUPPLEMENTS, 2007, 5 (08): : 35 - 35
  • [22] CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
    Rizzo, Stefania
    Petrella, Francesco
    Buscarino, Valentina
    De Maria, Federica
    Raimondi, Sara
    Barberis, Massimo
    Fumagalli, Caterina
    Spitaleri, Gianluca
    Rampinelli, Cristiano
    De Marinis, Filippo
    Spaggiari, Lorenzo
    Bellomi, Massimo
    EUROPEAN RADIOLOGY, 2016, 26 (01) : 32 - 42
  • [23] CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
    Stefania Rizzo
    Francesco Petrella
    Valentina Buscarino
    Federica De Maria
    Sara Raimondi
    Massimo Barberis
    Caterina Fumagalli
    Gianluca Spitaleri
    Cristiano Rampinelli
    Filippo De Marinis
    Lorenzo Spaggiari
    Massimo Bellomi
    European Radiology, 2016, 26 : 32 - 42
  • [24] Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC)
    Bluthgen, M. V.
    Caramella, C.
    Faivre, L.
    Rosellini, S.
    Facchinetti, F.
    Haspinger, E.
    Ferte, C.
    Ammari, S.
    Michiels, S.
    Soria, J. C.
    Besse, B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S645 - S646
  • [25] A phase II study of sorafenib in patients with stage IV non-small cell lung cancer (NSCLC) with a K-Ras mutation
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Groen, Harry J. M.
    van Wijk, Atie
    Burgers, Sjaak
    Kunst, Peter W. A.
    Thunnissen, Frederik B.
    Heideman, Danielle A. M.
    Smit, Egbert F.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [26] K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer:: a combined analysis of 881 cases
    Huncharek, M
    Muscat, J
    Geschwind, JF
    CARCINOGENESIS, 1999, 20 (08) : 1507 - 1510
  • [27] Prognostic significance of K-ras point mutations in the serum of patients with advanced non-smallcell lung cancer
    Sirera, R
    Bayo, P
    Martin, M
    Safont, MJ
    Blasco, A
    Caballero, C
    Garde, J
    Berrocal, A
    Ponce, R
    Camps, C
    LUNG CANCER, 2004, 45 : S28 - S28
  • [28] Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo).
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Helias-Rodzewicz, Zofia
    Dumoulin, Jennifer
    Giraud, Violaine
    Labrune, Sylvie
    Chinet, Thierry
    Emile, Jean-Francois
    Giroux-Leprieur, Etienne
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [29] The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
    Rinaldi, S.
    Santoni, M.
    Leoni, G.
    Fiordoliva, I.
    Marcantognini, G.
    Meletani, T.
    Armento, G.
    Santini, D.
    Newsom-Davis, T.
    Tiberi, M.
    Morgese, F.
    Torniai, M.
    Bower, M.
    Berardi, Rossana
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1255 - 1261
  • [30] Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Heideman, Danielle A. M.
    van Suylen, Robertjan
    Thunnissen, Frederik B.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
12345